NCT03977935View on ClinicalTrials.gov

The Second-Generation MCCG for Upper Gastrointestinal Tract.

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

July 18, 2019

Study Completion Date

July 25, 2019

Conditions
Capsule Endoscopy
Interventions
DEVICE

the second-generation MCCG

Patients in the experimental group swallowed the second-generation MCCG (Ankon Navicam-2).

Trial Locations (1)

200433

Changhai Hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER

NCT03977935 - The Second-Generation MCCG for Upper Gastrointestinal Tract. | Biotech Hunter | Biotech Hunter